Adrian P.M. van der Meijden

Author

Also Known As

ADRIAN P.M. VAN DER MEIJDEN, ADRIAN P.M. van der MEIJDEN, Adrian P. M. Van Der Meijden, Adrian P. M. van der Meijden, Adrian P.M Van Der Meijden, Adrian P.M. van der Meijden

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

Jeroen Bosch Ziekenhuis European Organisation for Research and Treatment of Cancer Ghent University Hospital Ospedale di Circolo e Fondazione Macchi European Organisation for Research and Treatment of Cancer

About

Adrian P.M. van der Meijden is an author at Jeroen Bosch Ziekenhuis specializing in oncology, medicine, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	3.5K
2	Pathology	2	2	44
3	Surgical Oncology	2	2	142
4	Cancer Therapeutics	2	2	371
5	Gynecology Oncology	1	1	122

Adrian P.M. van der Meijden

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, European Urology Individual PatientsUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicine	2006	2.9K
Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial Adrian P.M. van der Meijden, Richard Sylvester, W. Oosterlinck, European Urology European OrganisationUrologyMaintenance Bacillus Calmette-guerinUrologic Cancer EpidemiologyUrological Research	2003	288
INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIAL Adrian P.M. van der Meijden, Maurizio Brausi, Victor Zambon, The Journal of Urology	2001	139
EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in Situ Adrian P.M. van der Meijden, Richard Sylvester, Willem Oosterlinck, European Urology UrologySurgical OncologyGenitourinary CancerUrothelial CarcinomaMedicine	2005	122
Does Isoniazid Reduce Side Effects of Intravesical Bacillus Calmette-Guerin Therapy in Superficial Bladder Cancer? Interim Results of European Organization for Research and Treatment of Cancer Protocol 30911 P. D. J. Vegt, Adrian P.M. van der Meijden, Richard Sylvester, The Journal of Urology	1997	90
The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial Richard Sylvester, Adrian P.M. van der Meijden, W. Oosterlinck, European Urology European OrganisationUrologyBacillus Calmette-guerinUrological ResearchGenitourinary Cancer	2003	83
Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas Roland van Velthoven, Michel Pétein, Wim J Oosterlinck, Human Pathology UrologyTumoral PathologyGenitourinary CancerNuclear SizeMedicine	1995	24
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: Richard Sylvester, Adrian P.M. van der Meijden, Donald L. Lamm The Journal of Urology Urological ResearchUrologySurgical OncologyUrologic Cancer EpidemiologyGenitourinary Cancer	2002	20

Page 1